Latest From DNAnexus Inc.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Two recent next-generation sequencing draft guidances have been positively received so far by industry and clinical research groups. But for FDA's ideas to play out, more databases will need to be populated and more standards developed, agency officials say. There are also more guidances to come on different types of NGS tests. Read our coverage below, and also listen to our podcast interview with FDA's Elizabeth Mansfield.
China’s WuXi AppTec is planning separate new stock listings for various parts of its business in both China and Hong Kong, potentially raising billions of dollars in the wake of an earlier go-private transaction.
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Drug Discovery Tools
- Drug Discovery Tools
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- DNAnexus Inc.
- Senior Management
Richard Daly, CEO
Scott Gibson, CFO
David Shaywitz, MD, PhD, CMO
Brady Davis, VP, Strategy & Mktg.
Brad Sitko, VP, Fin. & Corp. Dev.
John Ellithorpe, PhD, Chief Product Officer
- Contact Info
Phone: (650) 969-3251
1975 W El Camino Real
Mountain View, CA 94040
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.